Medplus Health Services' subsidiary, Optival Health Solutions, faced a three-day drug license suspension at a store by the Drugs Control Administration, impacting operations by ₹0.01 Crore.
Value
₹0.01 Cr
From
Drugs Control Administration, Haveri Circle, Karnataka
Medplus Health Services reported a 7-day drug license suspension for a subsidiary store, impacting its operations with an estimated financial loss of ₹0.02 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, faced drug license suspensions for two stores from regulatory authorities, causing a total financial impact of Rs 0.0961 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, faced a five-day drug license suspension at its Kapikad store due to regulatory violations. The impact is Rs 0.03 Crore.
Medplus Health's subsidiary faces temporary drug license suspensions at two store locations in Bangalore and Pune, resulting in an estimated financial impact of Rs 0.15 Crore.
Medplus Health Services reported 7-day drug license suspensions for four stores across three states. The estimated financial impact of these operational disruptions is ₹0.09 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, faces temporary drug license suspensions for two stores. The estimated financial impact is Rs 0.03 Crore.
MedPlus's subsidiary, Optival Health Solutions, received a two-day drug license suspension for a store in Karnataka. The potential revenue impact is Rs 0.0071 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, received a two-day drug license suspension for a Karnataka store. The financial impact is estimated at ₹0.0029 Crore.
MedPlus Health Services' subsidiary, Optival Health, received two-day drug license suspensions for three stores. The total estimated potential revenue loss is ₹0.024 Crore.
MedPlus subsidiary Optival Health Solutions faces a 2-day drug license suspension at a Karnataka store, with a potential revenue loss of ₹0.0053 Crore.
MedPlus subsidiary Optival Health Solutions faced one to two-day drug license suspensions across three Karnataka stores. The estimated total revenue impact is approximately Rs. 1.59 lakhs.
Medplus subsidiary faces a two-day drug license suspension for one store in Davanagere. The estimated financial impact is 0.008 Crore due to regulatory non-compliance.
Medplus subsidiary Optival Health Solutions faced one-day drug license suspensions at two Karnataka stores. The regulatory action follows violations of the Drugs and Cosmetics Act.
MedPlus subsidiary Optival Health Solutions faced one-to-three-day license suspensions at three stores in Karnataka and Andhra Pradesh. Estimated financial impact is Rs 0.0158 Crore.
MedPlus subsidiary Optival Health's Karnataka store faced a one-day drug license suspension. This resulted in a potential revenue loss of ₹0.0046 Crore.
MedPlus subsidiary Optival Health Solutions faced a 15-day drug license suspension at its Ongole store. The disruption causes an estimated ₹0.02 Crore revenue loss.
MedPlus subsidiary Optival Health Solutions received drug license suspensions for two Telangana stores. The temporary closures result in a combined potential revenue loss of ₹0.01 Crore.
MedPlus subsidiary Optival Health Solutions received drug license suspension orders for two Karnataka stores. The temporary closures will result in a combined ₹0.03 Crore revenue loss.
MedPlus Health Services subsidiary received two drug license suspension orders for stores in Telangana and Karnataka. The suspensions cause a ₹0.05 Crore total potential revenue loss.
MedPlus subsidiary Optival Health Solutions received a three-day drug license suspension for a Telangana store. The event carries a potential ₹0.02 Crore revenue impact.
MedPlus subsidiary Optival Health Solutions received a two-day drug license suspension for its Karnataka store. The temporary closure results in a ₹0.01 Crore revenue loss.
